Try our beta test site
26 studies found for:    TAMSULOSIN AND DUTASTERIDE
Show Display Options
Rank Status Study
1 Completed This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride and Tamsulosin
2 Completed A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride (0.5mg); Tamsulosin hydrochloride (0.2mg); fixed dose combination product of duatsteride (0.5mg) and tamsulosin hydrochloride (0.2mg)
3 Completed Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride (0.5mg);   Drug: FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg);   Drug: Harnal D Tablets and Harnal Capsules (both comprising 0.2 mg tamsulosin HCl)
4 Terminated
Has Results
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Intervention: Drug: Dutasteride/Tamsulosin
5 Completed
Has Results
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Tamsulosin
6 Completed
Has Results
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
Condition: Prostatic Hyperplasia
Interventions: Drug: dutasteride 0.5mg once daily for 4 years;   Drug: tamsulosin 0.4mg once daily for 4 years
7 Completed Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Condition: Urologic Diseases
Interventions: Drug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg;   Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
8 Completed Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
Condition: Urologic Diseases
Interventions: Drug: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg;   Drug: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
9 Completed Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: FDC capsule of dutasteride and tamsulosin;   Drug: Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tablet
10 Completed A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride (0.5mg, fasted state);   Drug: Dutasteride (0.5mg, fed state);   Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state);   Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state);   Drug: Harnal-D Tablets with water (fasted state);   Drug: Harnal-D Tablets with water (fed state);   Drug: Harnal-D tablets without water (fasted state)
11 Completed Bioequivalence - Duodart Against Avodart & Omnic
Condition: Prostatic Hyperplasia
Interventions: Drug: dutasteride/tamsulosin;   Drug: dutasteride;   Drug: tamsulosin
12 Completed
Has Results
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride plus tamsulosin;   Drug: tamsulosin
13 Completed Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: tamsulosin and/or dutasteride
14 Active, not recruiting Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride 0.5mg capsules;   Drug: Dutasteride placebo capsules;   Drug: Tamsulosin 0.2mg tablets;   Drug: Disintegrating placebo tamsulosin tablet
15 Completed Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
Condition: Prostatic Hyperplasia
Interventions: Drug: Treatment sequence A;   Drug: Treatment sequence B;   Drug: Treatment sequence C
16 Completed A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
Condition: Prostatic Hyperplasia
Interventions: Drug: Treatment sequence A;   Drug: Treatment sequence B;   Drug: Treatment sequence C;   Drug: Treatment sequence D
17 Completed A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
Condition: Prostatic Hyperplasia
Intervention: Drug: GI198745
18 Terminated JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Conditions: Benign Prostatic Hyperplasia;   Chronic Prostatitis
Interventions: Drug: Jalyn;   Drug: Placebo
19 Completed Prospective Sexual Function Study for BPH Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride plus tamsulosin;   Drug: Placebo
20 Completed
Has Results
Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use
Condition: Prostatic Hyperplasia
Intervention: Drug: 5ARI + AB

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.